What is isoniazid?
Isoniazid is an antibacterial prescription medicine approved by the U.S.(FDA) for the prevention and treatment of (TB).
TB is an What is an Opportunistic Infection? fact sheet.(OI) of HIV. An OI is an that occurs more frequently or is more severe in people with weakened immune systems—such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the HIVinfo
To learn how HIV and TB are connected, read the HIVinfo HIV and Tuberculosis (TB) fact sheet. The fact sheet includes information on the difference between latent TB infection and active TB disease.
How is isoniazid used in people with HIV?
The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV include recommendations on the uses of isoniazid to treat:
- Latent TB infection in people with HIV to prevent the infection from advancing to active TB disease
- Active TB disease in people with HIV
The above list may not include all of the uses of isoniazid in people with HIV that are recommended in the guidelines. Some recommended uses, such as uses in certain rare circumstances, may have been omitted.
What should I tell my health care provider before taking isoniazid?
Before taking isoniazid, tell your health care provider:
- If you are allergic to isoniazid or any other medicines.
- About any medical conditions you have or have had, for example, nervous system or problems.
- About anything that could affect your ability to take medicines, such as difficulty swallowing tablets, difficulty remembering to take tablets or scheduled doses, or any health conditions that may prevent you from getting an injection (shot).
- If you are pregnant or plan to become pregnant. Isoniazid should be used as a treatment for active tuberculosis during pregnancy because the benefit justifies the potential risk to the . The benefit of preventive therapy also should be weighed against a possible risk to the fetus. Talk to your health care provider about possible risks with taking isoniazid when pregnant.
- If you are breastfeeding or plan to breastfeed. Do not breastfeed if you have HIV.
- About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Isoniazid may affect the way other medicines or products work, and other medicines or products may affect how isoniazid works. Ask your health care provider if there are interactions between isoniazid and the other medicines you take.
Ask your health care provider about possible side effects from isoniazid. Your health care provider will tell you what to do if you have side effects.
How should I take isoniazid?
Take isoniazid according to your health care provider’s instructions. Your health care provider will tell you how much isoniazid to take and when to take it. Before you start isoniazid and each time you get a refill, read any printed information that comes with your medicine.
How should isoniazid be stored?
- Store vials of isoniazid injection solution at 68°F to 77°F (20°C to 25°C) and protect them from light. The solution may crystallize (become solid) at low temperatures. If this occurs, warm the vial to room temperature before use to redissolve the crystals.
- Store isoniazid oral solution at room temperature, 68°F to 77°F (20°C to 25°C).
- Store isoniazid tablets at 68°F to 77°F (20°C to 25°C) and protect them from moisture and light.
- Keep isoniazid in the container that it came in and keep the container tightly closed.
- Do not use isoniazid if the original seal over the container opening is broken or missing.
- Throw away isoniazid that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
- Keep isoniazid and all medicines out of reach of children.
Where can I find more information about isoniazid?
More information about isoniazid is available:
- Recommendations on the HIV-related uses of isoniazid, from the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, prepared by the , the , and the HIV Medicine Association of the Diseases Society of America
- Isoniazid-related research studies, from
Last Reviewed: May 24, 2019